Your browser doesn't support javascript.
loading
ANZTCT practice statement: sinusoidal obstruction syndrome/veno-occlusive disease diagnosis and management.
Fleming, Shaun; Scott, Ashleigh P; Coutsouvelis, John; Fraser, Chris; Bajel, Ashish; Nelson, Adam; Conyers, Rachel; McEwan, Ashley; Yeung, David; Campion, Victoria; Teague, Lochie; McGuire, Matthew; Morris, Edward; Gabriel, Melissa; Wayte, Rebecca; Douglas, Genevieve; Chien, Nicole; Hamad, Nada.
Afiliação
  • Fleming S; Clinical Haematology, Alfred Hospital and Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Scott AP; Department of Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Coutsouvelis J; Pharmacy Department, Alfred Health, Melbourne, Victoria, Australia.
  • Fraser C; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
  • Bajel A; Blood and Marrow Transplant Service, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Nelson A; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Conyers R; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
  • McEwan A; Kids Cancer Centre, Sydney Children's Hospital, Sydney, New South Wales, Australia.
  • Yeung D; Pharmacogenomics Team, Stem Cell Biology, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Campion V; Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Teague L; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
  • McGuire M; Haematology Department, Liverpool Hospital, Sydney, New South Wales, Australia.
  • Morris E; South West Sydney Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Gabriel M; Royal Adelaide Hospital and Adelaide Medical School, Adelaide, South Australia, Australia.
  • Wayte R; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand.
  • Douglas G; Starship Blood and Cancer Center, Starship Children's Hospital, Auckland, New Zealand.
  • Chien N; Department of Pharmacy, Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • Hamad N; Department of Haematology and Bone Marrow Transplantation, Townsville University Hospital, Townsville, Queensland, Australia.
Intern Med J ; 54(9): 1548-1556, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39076028
ABSTRACT
Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a life-threatening complication which can develop after haemopoietic stem cell transplantation (HSCT) and some antibody-drug conjugates. Several SOS/VOD diagnostic and management guidelines exist, with the most recent and refined being the European Society for Blood and Marrow Transplantation adult and paediatric guidelines. Timely diagnosis and effective management (including the availability of therapeutic options) significantly contribute to improved patient outcomes. In Australia and New Zealand, there is variability in clinical practice and access to SOS/VOD therapies. This review aims to summarise the current evidence for SOS/VOD diagnosis, prevention and treatment and to provide recommendations for SOS/VOD in the context of contemporary Australasian HSCT clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Transplante de Células-Tronco Hematopoéticas Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Transplante de Células-Tronco Hematopoéticas Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2024 Tipo de documento: Article